SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parnax Lab reports Profit after tax of Rs 1.48 Mln, in the September 2021 quarter

20 Nov 2021 Evaluate
The total revenue stands at Rs. 23.19 millions for the September 2021 quarter. The mentioned figure indicates an increase of about 230.81% as against Rs. 7.01 millions during  the year-ago period.The Total Profit for the quarter ended September 2021 of Rs. 1.48 millions grew from Rs.-1.73 millionsOP of the company witnessed a marginal growth to 3.42 millions from 0.58 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 23.19 7.01 230.81 40.62 9.18 342.48 23.73 76.79 -69.10
Other Income 0.45 0.25 80.00 0.72 0.32 125.00 0.65 4.16 -84.38
PBIDT 3.42 0.58 489.66 8.19 -0.86 -1052.33 -3.79 9.50 -139.89
Interest 1.84 2.20 -16.36 3.65 4.37 -16.48 8.30 13.79 -39.81
PBDT 1.58 -1.62 -197.53 4.54 -5.23 -186.81 -12.09 -4.29 181.82
Depreciation 0.10 0.11 -9.09 0.20 0.22 -9.09 0.44 0.44 0.00
PBT 1.48 -1.73 -185.55 4.34 -5.45 -179.63 -12.53 -4.73 164.90
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -1.23 15.33 -108.02
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -2.56 15.33 -116.70
PAT 1.48 -1.73 -185.55 4.34 -5.45 -179.63 -11.30 -20.06 -43.67
Equity 85.05 85.05 0.00 85.05 85.05 0.00 85.05 85.05 0.00
PBIDTM(%) 14.75 8.27 78.24 20.16 -9.37 -315.22 -15.97 12.37 -229.10

Parnax Lab Share Price

137.05 3.00 (2.24%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: